David Chou

This inventor holds 9 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 8 EPO patents. Top assignee: Allergan, Inc.. Active years: 2011-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Chou. Retrieved from https://idiyas.com/inventor/david-chou-ec3lku9c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 5)

% Patents Active = 22.2

CIPO Patents = 2

EPO Patents = 8 (Patent Applications = 7)

Average Co-Inventor Count = 7.0

ph-index = 6

Forward Citations = 106(Granted Patents)

Company Filing History:

9 out of 2,287

Allergan, Inc.

patents

Years Active: 2011-2020

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10702539 - Ocular implant made by a double extrusion process (2020-07-07),

2. 10076526 - Ocular implant made by a double extrusion process (2018-09-18),

3. 9192511 - Ocular implant made by a double extrusion process (2015-11-24),

4. 8778381 - Ocular implant made by a double extrusion process (2014-07-15),

5. 8506987 - Ocular implant made by a double extrusion process (2013-08-13),

6. 8318070 - Ocular implant made by a double extrusion process (2012-11-27),

7. 8048445 - Ocular implant made by a double extrusion process (2011-11-01),

8. 8034370 - Ocular implant made by a double extrusion process (2011-10-11),

9. 8034366 - Ocular implant made by a double extrusion process (2011-10-11),

Title: David Chou: Innovator in Ocular Implants

Introduction

David Chou is a prominent inventor based in Palo Alto, CA (US). He has made significant contributions to the field of ocular implants, holding a total of 9 patents. His work focuses on developing innovative solutions for medical conditions affecting the eye.

Latest Patents

One of David Chou's latest patents is an ocular implant made by a double extrusion process. This invention provides biodegradable implants specifically designed for implantation in the ocular region. The implants are formed from a mixture of hydrophilic end and hydrophobic end PLGA, allowing for the delivery of active agents into the ocular region without a high burst release. This advancement represents a significant step forward in treating various medical conditions of the eye.

Career Highlights

David Chou is currently associated with Allergan, Inc., where he continues to push the boundaries of innovation in ocular health. His expertise and dedication to research have positioned him as a key player in the development of advanced medical technologies.

Collaborations

Throughout his career, David has collaborated with talented individuals such as Jane-Guo Shiah and Rahul Bhagat. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking inventions.

Conclusion

David Chou's contributions to the field of ocular implants highlight his commitment to improving medical treatments for eye conditions. His innovative patents and collaborations with other experts underscore his role as a leading inventor in this vital area of healthcare.

Profile summary based on public USPTO records.